{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:31:37Z","timestamp":1789716697703,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":4870,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1017\/s1041610211000895","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T12:49:08Z","timestamp":1307710148000},"page":"S41-S49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S2","title":["Amyloid imaging"],"prefix":"10.1016","volume":"23","author":[{"given":"Victor L.","family":"Villemagne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610211000895_bb0010","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000895_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiology of Aging"},{"key":"10.1017\/S1041610211000895_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/14737159.4.1.63","article-title":"Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease","volume":"4","author":"Chang","year":"2004","journal-title":"Expert Reviews in Molecular Diagnosis"},{"key":"10.1017\/S1041610211000895_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and beta-amyloid deposition in Alzheimer disease","volume":"67","author":"Chetelat","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000895_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000109754","article-title":"Biomarkers for early detection of Alzheimer pathology","volume":"16","author":"Clark","year":"2008","journal-title":"Neurosignals"},{"key":"10.1017\/S1041610211000895_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1017\/S1041610211000895_bb0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1017\/S1041610211000895_bb0045","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease","volume":"21","author":"Ellis","year":"2009","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610211000895_bb0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000895_bb0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","article-title":"[18F]-THK523, a novel in vivo tau imaging ligand for Alzheimer's disease","volume":"134","author":"Fodero-Tavoletti","year":"2011","journal-title":"Brain"},{"key":"10.1017\/S1041610211000895_bb0060","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1017\/S1041610211000895_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610211000895_bb0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.parkreldis.2007.07.010","article-title":"[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results","volume":"14","author":"Johansson","year":"2008","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1017\/S1041610211000895_bb0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","article-title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","volume":"62","author":"Johnson","year":"2007","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000895_bb0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1471-4159.2010.06812.x","article-title":"Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand","volume":"114","author":"Jureus","year":"2010","journal-title":"Journal of Neurochemistry"},{"key":"10.1017\/S1041610211000895_bb0085","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000895_bb0090","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","article-title":"Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees","volume":"27","author":"Klunk","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1017\/S1041610211000895_bb0095","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2006.03989.x","article-title":"Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics","volume":"97","author":"Masters","year":"2006","journal-title":"Journal of Neurochemistry"},{"key":"10.1017\/S1041610211000895_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-894X(01)00734-X","article-title":"A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain","volume":"12","author":"Mathis","year":"2002","journal-title":"Bioorganic Medical Chemistry Letters"},{"key":"10.1017\/S1041610211000895_bb0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000895_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","article-title":"Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease","volume":"17","author":"Morris","year":"2001","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1017\/S1041610211000895_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000895_bb0120","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.106.037762","article-title":"Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease","volume":"48","author":"Ng","year":"2007","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1017\/S1041610211000895_bb0125","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archneur.64.8.1140","article-title":"Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B","volume":"64","author":"Ng","year":"2007","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000895_bb0130","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jalz.2010.05.074","article-title":"Assessment of A\u03b2 deposition in mild cognitive impairment with 18F-florbetaben","volume":"6","author":"Ong","year":"2010","journal-title":"Alzheimer's and Dementia"},{"key":"10.1017\/S1041610211000895_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-956752","article-title":"Mild cognitive impairment: current research and clinical implications","volume":"27","author":"Petersen","year":"2007","journal-title":"Seminars in Neurology"},{"key":"10.1017\/S1041610211000895_bb0140","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1017\/S1041610211000895_bb0145","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","article-title":"11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration","volume":"68","author":"Rabinovici","year":"2007","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000895_bb0150","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1017\/S1041610211000895_bb0155","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000895_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid beta in Alzheimer's disease with (18)F-BAY94\u20139172, a novel PET tracer: proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610211000895_bb0165","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiology of Aging"},{"key":"10.1017\/S1041610211000895_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2010.05.209","article-title":"Florbetaben for beta-amyloid brain PET in Alzheimer's disease: results of a multicenter phase 2 trial","volume":"6","author":"Sabri","year":"2010","journal-title":"Alzheimer's and Dementia"},{"key":"10.1017\/S1041610211000895_bb0175","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jalz.2010.05.136","article-title":"Inter-ethnic comparability of pharmacokinetics of tlorbetaben (BAY 94\u20139172), a beta-amyloid imaging PET agent, as a basis of global development of a diagnostics for Alzheimer's disease","volume":"6","author":"Senda","year":"2010","journal-title":"Alzheimer's and Dementia"},{"key":"10.1017\/S1041610211000895_bb0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2176","article-title":"Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics","volume":"6","author":"Shaw","year":"2007","journal-title":"Nature Review of Drug Discoveries"},{"key":"10.1017\/S1041610211000895_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","article-title":"Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease","volume":"10","author":"Shoghi-Jadid","year":"2002","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610211000895_bb0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneurol.2007.23","article-title":"Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia","volume":"65","author":"Smith","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000895_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2009.04.088","article-title":"PET imaging of beta-amyloid with florpiramine F18 (18F-AV-45): preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease","volume":"5","author":"Sperling","year":"2009","journal-title":"Alzheimer's and Dementia"},{"key":"10.1017\/S1041610211000895_bb0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2967\/jnumed.108.056499","article-title":"Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET","volume":"50","author":"Tolboom","year":"2009","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1017\/S1041610211000895_bb0205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000895_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cpet.2009.12.008","article-title":"Amyloid ligands for dementia","volume":"5","author":"Villemagne","year":"2010","journal-title":"PET Clinics"},{"key":"10.1017\/S1041610211000895_bb0215","series-title":"Abeta Peptide and Alzheimer's Disease","first-page":"5","author":"Villemagne","year":"2006"},{"key":"10.1017\/S1041610211000895_bb0220","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","article-title":"Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease","volume":"46","author":"Villemagne","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1017\/S1041610211000895_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-008-8019-y","article-title":"The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias","volume":"38","author":"Villemagne","year":"2008","journal-title":"Molecular Neurobiology"},{"key":"10.1017\/S1041610211000895_bb0230","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archneurol.2009.285","article-title":"High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types","volume":"66","author":"Villemagne","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000895_bb0235","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/jnnp.2008.171496","article-title":"11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease","volume":"80","author":"Villemagne","year":"2009","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1017\/S1041610211000895_bb0240","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jalz.2010.05.210","article-title":"18F-Florbetaben-PET imaging in the differential diagnosis of dementia","volume":"6","author":"Villemagne","year":"2010","journal-title":"Alzheimer's and Dementia"},{"key":"10.1017\/S1041610211000895_bb0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000895_bb0250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"Journal of Nuclear Medicine"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224038912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224038912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610211000895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T20:34:05Z","timestamp":1736454845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224038912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":49,"alternative-id":["S1041610224038912"],"URL":"https:\/\/doi.org\/10.1017\/s1041610211000895","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid imaging","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610211000895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}